Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationMucosal immunology
View this publicationEpilepsia open
View this publicationScientific reports
View this publicationMed (New York, N.Y.)
View this publicationJournal of fungi (Basel, Switzerland)
View this publicationCell stress & chaperones
View this publicationThe Lancet. Infectious diseases
View this publicationFrontiers in immunology
View this publicationHeart (British Cardiac Society)
View this publication